Bayer says October U.S. glyphosate trial delayed until February

This post was originally published on this site
https://i-invdn-com.akamaized.net/trkd-images/LYNXMPEF950IO_L.jpg
© Reuters. FILE PHOTO: Logo of Bayer AG at a plant of the German pharmaceutical and chemical maker in Wuppertal© Reuters. FILE PHOTO: Logo of Bayer AG at a plant of the German pharmaceutical and chemical maker in Wuppertal

FRANKFURT (Reuters) – A pending U.S. lawsuit over claims related to Bayer’s (DE:) glyphosate-based herbicide Roundup has been delayed, the company said on Sunday, with a new court date set for February, 2020.

“The Oct. 15, 2019 trial date for Winston v. Monsanto (NYSE:) in St. Louis City has been postponed,” Bayer said in a statement.

The lawsuit is the latest of several to be delayed as mediator Ken Feinberg tries to negotiate a settlement between the company and U.S. plaintiffs after a California jury in August last year found that Monsanto should have warned of alleged cancer risks.

“With the change in the trial schedule and no trial dates set through the rest of the year, the appeals of the three completed trials will be a significant focus of the litigation in the months ahead,” Bayer said.

Handelsblatt first reported the latest delay earlier on Sunday.

A court document from the Circuit Court of the City of St. Louis, dated October 4, said a new court date had been set for February 10.

The number of U.S. plaintiffs blaming Roundup and other glyphosate-based weed killers for cancer has been rising continuously to stand at 18,400 as of July 11, hitting Bayer’s share price.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Add Comment